![]() Navidea Biopharmaceuticals Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. | ![]() Adaptive Biotechnologies Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease. | ![]() Artms Artms is a company that develops technologies designed to enable the production of diagnostic imaging isotope. | ||
Founding Date | Founding Date 1983 | Founding Date 2009 | Founding Date 1923 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Dublin, US HQ Thame, GB | Locations Seattle, US HQ New York, US South San Francisco, US | Locations Hørsholm, DK HQ | Locations Burnaby, CA HQ |
Employees | Employees 137% decrease | Employees 70910% decrease | Employees 2,736 | Employees 283% decrease |
Valuation ($) | Valuation ($) 100.1 k | Valuation ($) 694.6 m | Valuation ($) 6.1 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $65.7k (FY, 2022) | Revenue (est.) $277m (FY, 2025) | Revenue (est.) kr6.3b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $1.9k (FY, 2022) | Cost of goods $71.4m (FY, 2025) | Cost of goods kr1.8b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ($119.3k) (FY, 2022) | Gross profit $205.6m (FY, 2025) | Gross profit kr4.5b (FY, 2025) | Gross profit N/A |
Net income | Net income ($15.2m) (FY, 2022) | Net income ($59.5m) (FY, 2025) | Net income kr1.2b (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 525m | Total funding raised N/A | Total funding raised $ 22m |

Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease.
View company
Alk Abello A/S is a Denmark-based company active within the pharmaceutical industry.
View company
Artms is a company that develops technologies designed to enable the production of diagnostic imaging isotope.
View company